Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Ma Xing Shi Gan Decoction in Treating Acute Exacerbations of Chronic Obstructive Pulmonary Disease
NCT07403032Not yet recruiting
- Start
- Jan 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
01
Overview
Randomised trial of modified Ma Xing Shi Gan Decoction in chronic obstructive pulmonary disease (COPD) (2 arms). Primary endpoint: Length of Hospital Stay at 14 days. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
modified Ma Xing Shi Gan Decoction
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07403032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07403032.